349 related articles for article (PubMed ID: 32732334)
21. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
[TBL] [Abstract][Full Text] [Related]
22. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
[TBL] [Abstract][Full Text] [Related]
23. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Yeoh SE; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905
[TBL] [Abstract][Full Text] [Related]
24. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
25. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Broderick C; Yeoh SE; Stansby G
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD010837. PubMed ID: 34597414
[TBL] [Abstract][Full Text] [Related]
26. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.
Wille MM; Dirksen A; Ashraf H; Saghir Z; Bach KS; Brodersen J; Clementsen PF; Hansen H; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thomsen LH; Tønnesen P; Pedersen JH
Am J Respir Crit Care Med; 2016 Mar; 193(5):542-51. PubMed ID: 26485620
[TBL] [Abstract][Full Text] [Related]
27. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
Yousaf-Khan U; van der Aalst C; de Jong PA; Heuvelmans M; Scholten E; Lammers JW; van Ooijen P; Nackaerts K; Weenink C; Groen H; Vliegenthart R; Ten Haaf K; Oudkerk M; de Koning H
Thorax; 2017 Jan; 72(1):48-56. PubMed ID: 27364640
[TBL] [Abstract][Full Text] [Related]
28. Clinical effectiveness and cost-effectiveness of endobronchial and endoscopic ultrasound relative to surgical staging in potentially resectable lung cancer: results from the ASTER randomised controlled trial.
Sharples LD; Jackson C; Wheaton E; Griffith G; Annema JT; Dooms C; Tournoy KG; Deschepper E; Hughes V; Magee L; Buxton M; Rintoul RC
Health Technol Assess; 2012; 16(18):1-75, iii-iv. PubMed ID: 22472180
[TBL] [Abstract][Full Text] [Related]
29. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.
Pastorino U; Sverzellati N; Sestini S; Silva M; Sabia F; Boeri M; Cantarutti A; Sozzi G; Corrao G; Marchianò A
Eur J Cancer; 2019 Sep; 118():142-148. PubMed ID: 31336289
[TBL] [Abstract][Full Text] [Related]
30. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai.
Mittra I; Mishra GA; Dikshit RP; Gupta S; Kulkarni VY; Shaikh HKA; Shastri SS; Hawaldar R; Gupta S; Pramesh CS; Badwe RA
BMJ; 2021 Feb; 372():n256. PubMed ID: 33627312
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
[TBL] [Abstract][Full Text] [Related]
32. Lung cancer CT screening: Psychological responses in the presence and absence of pulmonary nodules.
Clark ME; Bedford LE; Young B; Robertson JFR; das Nair R; Vedhara K; Littleford R; Sullivan FM; Mair FS; Schembri S; Rauchhaus P; Kendrick D
Lung Cancer; 2018 Oct; 124():160-167. PubMed ID: 30268456
[TBL] [Abstract][Full Text] [Related]
33. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
[TBL] [Abstract][Full Text] [Related]
34. Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools.
Feng X; Wu WY; Onwuka JU; Haider Z; Alcala K; Smith-Byrne K; Zahed H; Guida F; Wang R; Bassett JK; Stevens V; Wang Y; Weinstein S; Freedman ND; Chen C; Tinker L; Nøst TH; Koh WP; Muller D; Colorado-Yohar SM; Tumino R; Hung RJ; Amos CI; Lin X; Zhang X; Arslan AA; Sánchez MJ; Sørgjerd EP; Severi G; Hveem K; Brennan P; Langhammer A; Milne RL; Yuan JM; Melin B; Johansson M; Robbins HA; Johansson M
J Natl Cancer Inst; 2023 Sep; 115(9):1050-1059. PubMed ID: 37260165
[TBL] [Abstract][Full Text] [Related]
35. Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Hocking WG; Hu P; Oken MM; Winslow SD; Kvale PA; Prorok PC; Ragard LR; Commins J; Lynch DA; Andriole GL; Buys SS; Fouad MN; Fuhrman CR; Isaacs C; Yokochi LA; Riley TL; Pinsky PF; Gohagan JK; Berg CD;
J Natl Cancer Inst; 2010 May; 102(10):722-31. PubMed ID: 20442215
[TBL] [Abstract][Full Text] [Related]
36. Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening.
Thomas A; Pattanayak P; Szabo E; Pinsky P
Chest; 2018 Dec; 154(6):1284-1290. PubMed ID: 30080997
[TBL] [Abstract][Full Text] [Related]
37. Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial.
Robin P; Le Roux PY; Planquette B; Accassat S; Roy PM; Couturaud F; Ghazzar N; Prevot-Bitot N; Couturier O; Delluc A; Sanchez O; Tardy B; Le Gal G; Salaun PY;
Lancet Oncol; 2016 Feb; 17(2):193-199. PubMed ID: 26672686
[TBL] [Abstract][Full Text] [Related]
38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
39. Ability of low-dose helical CT to distinguish between benign and malignant noncalcified lung nodules.
Markowitz SB; Miller A; Miller J; Manowitz A; Kieding S; Sider L; Morabia A
Chest; 2007 Apr; 131(4):1028-34. PubMed ID: 17426206
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]